26th Sep 2023 12:18
(Alliance News) - Belluscura PLC on Tuesday said it received approval from the Hong Kong Department of Health to distribute the X-plor portable oxygen concentrator.
The London-headquartered medical device developer said the approval from the Hong Kong body's medical device division comes alongside the company already receiving its first purchase order from a Hong Kong distributor.
Hong Kong is part of the licensed territory in its exclusive license agreement signed last month with Innomax Medical Device Technologies, Belluscura said.
Belluscura also announced the successful completion of the Discov-r portable oxygen concentrator patient usability study, with all participants providing "favourable" feedback on the device.
Initial production of Discov-r will commence this week, Belluscura said, with full-scale production being planned in conjunction with Innomax in response to the "significant preliminary demand" already received by the company.
"We are very excited to receive the approval and begin sales in Hong Kong. I am very pleased with our operations, quality control and sales teams receiving approval ahead of schedule. Hong Kong is phase one of our joint expansion with Innomax into Asia," said Chief Executive Officer Bob Rauker.
Shares in Belluscura were up 4.0% to 39.00 pence each in London on Tuesday afternoon.
By Greg Rosenvinge, Alliance News reporter
Comments and questions to [email protected]
Copyright 2023 Alliance News Ltd. All Rights Reserved.
Related Shares:
Belluscura